CoStim Pharmaceuticals

About:

CoStim Pharmaceuticals Inc. operates as a biotechnology company. It develops antibody agents for treatment of cancer. The company was

Website: http://costim.com

Top Investors: Atlas Venture, MPM Capital, Johnson & Johnson Development Corporation, Partners Innovation Fund

Description:

CoStim Pharmaceuticals Inc. operates as a biotechnology company. It develops antibody agents for treatment of cancer. The company was incorporated in 2011 and is based in Boston, Massachusetts.

Total Funding Amount:

$22M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2011-01-01

Founders:

Luke Evnin, Robert Millman

Number of Employees:

11-50

Last Funding Date:

2013-03-01

IPO Status:

Private

Industries: